DUPONT CAPITAL MANAGEMENT CORP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$156,000
-3.7%
14,2890.0%0.01%0.0%
Q1 2022$162,000
-33.6%
14,289
-8.1%
0.01%
-22.2%
Q4 2021$244,000
-34.6%
15,553
-28.5%
0.01%
-25.0%
Q3 2021$373,000
-64.4%
21,754
-55.3%
0.01%
-52.0%
Q2 2021$1,047,000
+43.2%
48,6690.0%0.02%
+38.9%
Q1 2021$731,000
-5.2%
48,669
-17.0%
0.02%
+12.5%
Q4 2020$771,000
+88.5%
58,651
+135.6%
0.02%
+77.8%
Q4 2019$409,000
+23.6%
24,8960.0%0.01%
+12.5%
Q3 2019$331,000
-36.1%
24,896
-11.6%
0.01%
-33.3%
Q1 2019$518,000
-56.1%
28,171
-37.6%
0.01%
-58.6%
Q4 2018$1,180,000
+13.8%
45,1670.0%0.03%
+26.1%
Q3 2018$1,037,000
+20.6%
45,1670.0%0.02%
+15.0%
Q2 2018$860,000
+13.0%
45,1670.0%0.02%
+11.1%
Q1 2018$761,000
-32.2%
45,167
-38.9%
0.02%
-30.8%
Q4 2017$1,123,000
-15.1%
73,8700.0%0.03%
-13.3%
Q3 2017$1,322,00073,8700.03%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders